• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

微血管血栓形成是重症 COVID-19 的关键因素。

Microvascular Thrombosis as a Critical Factor in Severe COVID-19.

机构信息

Division of Angiology, Department of Internal Medicine II, Medical University of Vienna, 1090 Vienna, Austria.

Department of Medical Biotechnology, Faculty of Biophysics, Biochemistry and Biotechnology, Jagiellonian University, 30-387 Krakow, Poland.

出版信息

Int J Mol Sci. 2023 Jan 27;24(3):2492. doi: 10.3390/ijms24032492.

DOI:10.3390/ijms24032492
PMID:36768817
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9916726/
Abstract

Platelet-endothelial interactions have a critical role in microcirculatory function, which maintains tissue homeostasis. The subtle equilibrium between platelets and the vessel wall is disturbed by the coronavirus disease 2019 (COVID-19), which affects all three components of Virchow's triad (endothelial injury, stasis and a hypercoagulable state). Endotheliitis, vasculitis, glycocalyx degradation, alterations in blood flow and viscosity, neutrophil extracellular trap formation and microparticle shedding are only few pathomechanisms contributing to endothelial damage and microthrombosis resulting in capillary plugging and tissue ischemia. In the following opinion paper, we discuss major pathological processes leading to microvascular endothelial activation and thrombosis formation as a possible major adverse factor driving the deterioration of patient disease course in severe COVID-19.

摘要

血小板-内皮细胞相互作用在维持组织稳态的微循环功能中起着关键作用。新型冠状病毒病 2019(COVID-19)破坏了这种微妙的平衡,影响了Virchow 三联征的所有三个组成部分(内皮损伤、停滞和高凝状态)。内皮炎、血管炎、糖萼降解、血流和粘度改变、中性粒细胞胞外诱捕网形成和微粒体脱落只是导致内皮损伤和微血栓形成的部分病理机制,导致毛细血管堵塞和组织缺血。在这篇专题讨论文章中,我们讨论了导致微血管内皮激活和血栓形成的主要病理过程,这可能是严重 COVID-19 患者病情恶化的一个主要不利因素。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c16/9916726/692bf8effec1/ijms-24-02492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c16/9916726/692bf8effec1/ijms-24-02492-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/3c16/9916726/692bf8effec1/ijms-24-02492-g001.jpg

相似文献

1
Microvascular Thrombosis as a Critical Factor in Severe COVID-19.微血管血栓形成是重症 COVID-19 的关键因素。
Int J Mol Sci. 2023 Jan 27;24(3):2492. doi: 10.3390/ijms24032492.
2
Thrombosis in Coronavirus disease 2019 (COVID-19) through the prism of Virchow's triad.新冠肺炎(COVID-19)中的血栓形成——从维柯氏三联征的角度来看。
Clin Rheumatol. 2020 Sep;39(9):2529-2543. doi: 10.1007/s10067-020-05275-1. Epub 2020 Jul 11.
3
Procoagulant activity in hemostasis and thrombosis: Virchow's triad revisited.在止血和血栓形成中的促凝活性:重新审视维科三要素。
Anesth Analg. 2012 Feb;114(2):275-85. doi: 10.1213/ANE.0b013e31823a088c. Epub 2011 Nov 21.
4
Virchow's triad revisited: abnormal flow.重温魏尔啸三联征:血流异常。
Pathophysiol Haemost Thromb. 2003;33(5-6):455-7. doi: 10.1159/000083845.
5
COVID-19 and thrombosis: The role of hemodynamics.COVID-19 与血栓:血液动力学的作用。
Thromb Res. 2022 Apr;212:51-57. doi: 10.1016/j.thromres.2022.02.016. Epub 2022 Feb 23.
6
Ranking the contributing risk factors in venous thrombosis in terms of therapeutic potential: Virchow's triad revisited.从治疗潜力角度对静脉血栓形成的相关危险因素进行排序:重新审视魏尔啸三联征。
J Obstet Gynaecol Res. 2006 Apr;32(2):216-23. doi: 10.1111/j.1447-0756.2006.00374.x.
7
Thromboinflammation in long COVID-the elusive key to postinfection sequelae?长新冠中的血栓炎症——感染后后遗症难以捉摸的关键?
J Thromb Haemost. 2023 Aug;21(8):2020-2031. doi: 10.1016/j.jtha.2023.04.039. Epub 2023 May 11.
8
Mechanisms of venous and arterial thrombosis in heparin-induced thrombocytopenia.肝素诱导的血小板减少症中静脉和动脉血栓形成的机制。
J Thromb Thrombolysis. 2000 Nov;10 Suppl 1:13-20. doi: 10.1023/a:1027372901367.
9
Myocardial Oedema as a Consequence of Viral Infection and Persistence-A Narrative Review with Focus on COVID-19 and Post COVID Sequelae.心肌水肿作为病毒感染和持续存在的后果——以 COVID-19 和新冠后遗症为重点的叙述性综述。
Viruses. 2024 Jan 14;16(1):121. doi: 10.3390/v16010121.
10
The impact of platelets on pulmonary microcirculation throughout COVID-19 and its persistent activating factors.血小板对 COVID-19 全病程及持续激活因素肺微循环的影响。
Front Immunol. 2022 Sep 28;13:955654. doi: 10.3389/fimmu.2022.955654. eCollection 2022.

引用本文的文献

1
Friend or foe: the role of platelets in acute lung injury.敌友之间:血小板在急性肺损伤中的作用
Front Immunol. 2025 May 14;16:1556923. doi: 10.3389/fimmu.2025.1556923. eCollection 2025.
2
Glycocalyx Disintegration Is Associated with Mortality in Chronic Heart Failure.糖萼解体与慢性心力衰竭患者的死亡率相关。
J Clin Med. 2025 May 20;14(10):3571. doi: 10.3390/jcm14103571.
3
The characteristics of multimodal fundus imaging in AMN patients following COVID infection.新冠感染后急性黄斑神经视网膜病变(AMN)患者的多模态眼底成像特征

本文引用的文献

1
Fibrinolysis shut down in COVID-19 patients: Report on two severe cases with potential diagnostic and clinical relevance.COVID-19患者的纤维蛋白溶解功能关闭:两例具有潜在诊断和临床意义的重症病例报告。
Thromb Update. 2020 Dec;1:100008. doi: 10.1016/j.tru.2020.100008. Epub 2020 Aug 26.
2
Cardiovascular Disease Management in the Context of Global Crisis.全球危机背景下的心血管疾病管理。
Int J Environ Res Public Health. 2022 Dec 30;20(1):689. doi: 10.3390/ijerph20010689.
3
Tissue factor links inflammation, thrombosis, and senescence in COVID-19.
Sci Rep. 2025 May 8;15(1):16104. doi: 10.1038/s41598-025-99442-6.
4
Cholinesterase and Inflammation: Exploring Its Role and Associations with Inflammatory Markers in Patients with Lower Extremity Artery Disease.胆碱酯酶与炎症:探讨其在下肢动脉疾病患者中的作用及其与炎症标志物的关联。
Biomedicines. 2025 Mar 30;13(4):823. doi: 10.3390/biomedicines13040823.
5
Impacts of the COVID-19 pandemic on pediatric and adult patients with hemophilia.2019年冠状病毒病疫情对血友病儿童及成人患者的影响。
Ann Hematol. 2025 Jan;104(1):95-104. doi: 10.1007/s00277-024-05992-6. Epub 2024 Sep 14.
6
The COVID-19 thrombus: distinguishing pathological, mechanistic, and phenotypic features and management.新型冠状病毒肺炎血栓形成:区分病理、机制、表型特征及管理
J Thromb Thrombolysis. 2025 Jan;58(1):15-49. doi: 10.1007/s11239-024-03028-4. Epub 2024 Aug 23.
7
Evaluation of circulating microvesicles and their procoagulant activity in patients with COVID-19.评价 COVID-19 患者的循环微囊泡及其促凝活性。
BMC Res Notes. 2024 Aug 22;17(1):233. doi: 10.1186/s13104-024-06875-9.
8
The Role of Heparin in Postural Orthostatic Tachycardia Syndrome and Other Post-Acute Sequelae of COVID-19.肝素在体位性直立性心动过速综合征及新冠病毒感染后急性后遗症中的作用
J Clin Med. 2024 Apr 20;13(8):2405. doi: 10.3390/jcm13082405.
9
Morphology and Function of Red Blood Cells in COVID-19 Patients: Current Overview 2023.2023年新冠病毒感染患者红细胞的形态与功能:当前概述
Life (Basel). 2024 Apr 1;14(4):460. doi: 10.3390/life14040460.
10
Fibrinaloid Microclots and Atrial Fibrillation.纤维蛋白样微血栓与心房颤动
Biomedicines. 2024 Apr 17;12(4):891. doi: 10.3390/biomedicines12040891.
组织因子将 COVID-19 中的炎症、血栓形成和衰老联系起来。
Sci Rep. 2022 Nov 18;12(1):19842. doi: 10.1038/s41598-022-23950-y.
4
A persistent neutrophil-associated immune signature characterizes post-COVID-19 pulmonary sequelae.持续性中性粒细胞相关免疫特征可作为新冠病毒感染后肺部后遗症的标志物。
Sci Transl Med. 2022 Nov 16;14(671):eabo5795. doi: 10.1126/scitranslmed.abo5795.
5
Endothelial dysfunction in COVID-19: an overview of evidence, biomarkers, mechanisms and potential therapies.COVID-19 中的血管内皮功能障碍:证据、生物标志物、机制和潜在治疗方法概述。
Acta Pharmacol Sin. 2023 Apr;44(4):695-709. doi: 10.1038/s41401-022-00998-0. Epub 2022 Oct 17.
6
Complementary Sets of Autoantibodies Induced by SARS-CoV-2, Adenovirus and Bacterial Antigens Cross-React with Human Blood Protein Antigens in COVID-19 Coagulopathies.SARS-CoV-2、腺病毒和细菌抗原诱导的互补自身抗体与 COVID-19 凝血障碍中的人血蛋白抗原发生交叉反应。
Int J Mol Sci. 2022 Sep 29;23(19):11500. doi: 10.3390/ijms231911500.
7
Tissue Factor and COVID-19: An Update.组织因子与2019冠状病毒病:最新进展
Curr Drug Targets. 2022 Nov 15;23(17):1573-1577. doi: 10.2174/1389450123666220926144432.
8
Canakinumab in patients with COVID-19 and type 2 diabetes - A multicentre, randomised, double-blind, placebo-controlled trial.卡那单抗用于2型糖尿病合并新型冠状病毒肺炎患者——一项多中心、随机、双盲、安慰剂对照试验
EClinicalMedicine. 2022 Sep 17;53:101649. doi: 10.1016/j.eclinm.2022.101649. eCollection 2022 Nov.
9
Long Covid: where we stand and challenges ahead.长新冠:现状与未来挑战
Cell Death Differ. 2022 Oct;29(10):1891-1900. doi: 10.1038/s41418-022-01052-6. Epub 2022 Sep 7.
10
The collateral damage of COVID-19 to cardiovascular services: a meta-analysis.COVID-19 对心血管服务的附带损害:一项荟萃分析。
Eur Heart J. 2022 Sep 1;43(33):3164-3178. doi: 10.1093/eurheartj/ehac227.